O'Connor Daniel J. 4

What Happened

• Daniel J. O'Connor, a director of DiaMedica Therapeutics Inc. (DMAC), was granted a derivative award of 40,412 shares on 2026-06-01. The award was reported on a Form 4 filed 2026-06-03. The reported acquisition price is $0.00, so the immediate reported dollar value is $0; the award is recorded as a derivative grant (transaction code A).

Key Details

• Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (timely filing).
• Grant: 40,412 shares; reported price: $0.00 (derivative award).
• Shares owned after transaction: not specified in the filing.
• Footnote: The award is scheduled to vest in four equal quarterly installments (i.e., quarterly vesting over one year).
• No sale, purchase, or tax-withholding reported in this filing.

Context

• This was a grant/award to a director (compensation), not an open-market purchase or sale. Derivative awards typically convert to owned shares only as they vest, so this grant does not represent immediate share ownership or a sale. Such director awards are common as compensation and are not a direct buy/sell signal.